On February 1, 2024, the UW Program for Advanced Cell Therapy sponsored MARSH phase 1 clinical trial treated its first patient at UW Carbone Cancer Center. This National Institute of Dental and Craniofacial Research (NIDCR) …
Integrated personalized cell technologies for improving health outcomes in children and adults